Drug shortages: New regulations for supply in Germany
The supply of essential medicines is currently a key topic in Germany. Many patients and pharmacists regularly report supply shortages for drugs such as antibiotics, fever syrups, or blood pressure medication. To improve the situation, the federal government has introduced new legal measures intended to secure access to vital preparations.
A key point of the new regulations is the strengthening of production within Europe. In recent years, many medicines were manufactured in Asia, which made supply chains vulnerable to disruptions. Now, incentives are to be created so that pharmaceutical companies increasingly relocate their production back to Germany or other EU countries. This is intended to reduce dependency on global markets.
Additionally, pharmacies are being granted more flexibility. If a specific medication is unavailable, pharmacists are permitted to switch to a comparable product under certain conditions without the doctor having to issue a new prescription. The goal here is clear: a lack of supply on the market must not result in the patient ultimately being left without necessary treatment.
Experts emphasize, however, that these measures will take time to have their full effect. The challenges in global logistics and increased raw material costs remain. Nevertheless, many experts see the new laws as an important step toward stabilizing drug safety in Germany in the long term and making patient care more reliable.